While structurally related to arginine-specific ADP-ribosyltransferases, human ART4 lacks catalytic activity due to non-conservative substitutions in the R-S-EXE motif, a critical active-site sequence . Key findings include:
Chicken ART4 retains an intact R-S-EXE motif and exhibits arginine-specific enzyme activity ( for etheno-NAD) .
Mutagenesis studies restoring the R-S-EXE motif in human ART4 (e.g., Y187R, K242E mutations) failed to activate enzymatic function, suggesting additional residues are required for catalysis .
Mammalian ART4 (including humans and mice) diverged from non-mammalian orthologues, losing enzymatic activity during evolution .
The RGD motif in ART4 (Arg-Gly-Asp) may mediate cell adhesion, though its role remains under investigation .
ART4 harbors antigens of the Dombrock blood group system, critical for transfusion medicine:
Antigen | Clinical Significance |
---|---|
DOA/DOB | Common alleles; mismatched transfusions cause hemolytic reactions |
DO*JO1 | Rare variant linked to severe transfusion complications |
DOHY1/DOHY2 | High-frequency antigens; absence leads to alloimmunization in transfusion recipients |
ART4’s GPI-anchored structure on erythrocytes makes it a target for antibody-mediated transfusion reactions .
ART4 expression is modulated during erythropoiesis and by external factors (e.g., cytokines) .
Polymorphisms in ART4 correlate with antigenic variability in the Dombrock system .
Transfusion Medicine: ART4 variants necessitate precise blood typing to prevent alloimmunization .
Research Tools: Recombinant ART4 (e.g., ENZ-1072) is used to study blood group biochemistry and autoimmune disorders .
Investigating ART4’s non-enzymatic roles (e.g., cell adhesion or signaling).
Developing universal donor blood products by engineering ART4-null erythrocytes.
ARTC4, DOK1, CD297 Antigen, Dombrock Blood Group, ADP-Ribosyltransferase 4, Ecto-ADP-Ribosyltransferase 4.
Sf9, Insect cells.
ADPSEVAIKI DFDFAPGSFD DQYQGCSKQV MEKLTQGDYF TKDIEAQKNY FRMWQKAHLA WLNQGKVLPQ NMTTTHAVAI LFYTLNSNVH SDFTRAMASV ARTPQQYERS FHFKYLHYYL TSAIQLLRKD SIMENGTLCY EVHYRTKDVH FNAYTGATIR FGQFLSTSLL KEEAQEFGNQ TLFTIFTCLG APVQYFSLKK EVLIPPYELF KVINMSYHPR GDWLQLRSTG NLSTYNCQLL KAHHHHHH.
ART4 (ADP-Ribosyltransferase 4) is a glycosylphosphatidylinositol (GPI)-linked membrane protein that carries Dombrock blood group antigens. It belongs to the Ribosyltransferase family and contains a mono-ADP-ribosylation (ART) motif, although its enzymatic activity has not been conclusively demonstrated experimentally .
The mature human ART4 protein consists of 239 amino acids (positions 47-285) with a molecular mass of approximately 28.8 kDa, though it typically appears as 28-40 kDa on SDS-PAGE due to glycosylation . The protein is anchored to the erythrocyte membrane via a GPI anchor and has several sites for post-translational modifications, including phosphorylation at positions Ser307, Ser308, Tyr362, and Tyr398 .
When working with ART4, researchers should consider:
The presence of the GPI anchor affects membrane localization and protein behavior
Glycosylation patterns may influence protein function and antibody recognition
The mature protein (aa 47-285) rather than the full-length sequence should be used for recombinant protein expression
ART4 shows developmental regulation with highest expression levels in the fetal liver . Its expression appears to be tightly controlled during erythroid differentiation, suggesting a specific role in red blood cell development .
For researchers investigating ART4 expression patterns:
Compare expression across developmental stages and cell lineages
Employ erythroid differentiation models to track temporal expression changes
Use specific antibodies validated for detecting ART4 in different applications (WB, IHC)
Consider tissue-specific expression patterns when designing experiments
The relationship between ART4 expression and erythroid development makes it an interesting target for hematological research, particularly in understanding the molecular basis of erythropoiesis.
ART4 serves as the molecular carrier of the Dombrock blood group antigens. Several antigens have been identified in this system, including DOA, DOJO1, DOA-WL, DODOYA, DOB, DOB-WL, DOB-SH-Q149K, DOB-(WL)-I175N, DOHY1, DOHY2, and DO*DOMR .
These antigens result from allelic variations in the ART4 gene. Some of these variations lead to adverse transfusion reactions, making them clinically significant . For blood typing research, understanding the molecular basis of these variations is critical for:
Developing improved blood typing methodologies
Investigating immunological responses to transfusions
Studying the structure-function relationships of ART4 variants
Based on the available research tools, the following options have been validated for ART4 research:
Antibodies:
Polyclonal antibodies targeting specific regions (aa 61-160, 181-230, 1-314)
Phospho-specific antibodies for post-translational modifications (Ser307, Ser308, Tyr362, Tyr398)
Antibody Selection Table:
Target Region | Host | Clonality | Validated Applications | Species Reactivity |
---|---|---|---|---|
AA 61-160 | Mouse/Rabbit | Polyclonal | WB, ELISA | Human |
AA 181-230 | Rabbit | Polyclonal | ELISA, IHC | Human |
AA 1-314 | Mouse | Polyclonal | WB | Human |
Ser307 | Rabbit | Polyclonal | WB, ELISA, IHC, IF | Human, Mouse, Rat |
Tyr362 | Rabbit | Polyclonal | WB, ELISA, IF | Human, Mouse, Rat |
Recombinant Proteins:
Human ART4 recombinant protein expressed in Sf9 insect cells (aa 47-285)
For optimal experimental results, researchers should:
Validate antibodies in their specific experimental systems
Consider the specific application requirements (Western blot, IHC, etc.)
Select appropriate species reactivity for comparative studies
Use recombinant proteins as positive controls and standards
Despite belonging to the ADP-ribosyltransferase family, ART4's enzymatic activity remains to be conclusively demonstrated. When designing experiments to investigate this activity:
In vitro enzymatic assays:
Structural considerations:
Analyze the conservation of catalytic residues compared to enzymatically active ART family members
Design mutations of predicted catalytic sites to test structure-function relationships
Consider the impact of post-translational modifications on potential activity
Experimental controls:
Generate catalytically inactive mutants as negative controls
Include assays with and without potential cofactors
Consider the effect of membrane association via the GPI anchor on activity
For researchers planning gene modification approaches to study ART4 function:
Model system selection:
Verification strategies:
Experimental design considerations:
Include heterozygous models to study gene dosage effects
Implement proper controls (age and sex-matched, isogenic)
Analyze both cellular and systemic phenotypes
Consider temporal aspects for developmental studies
Specific phenotypes to analyze:
Erythroid differentiation and maturation
Membrane protein composition
Blood group antigen expression
Cellular response to physiological stressors
To address conflicting reports about ART4 function, especially regarding its enzymatic activity:
Systematically evaluate methodological differences:
Compare protein preparations (recombinant vs. native, different expression systems)
Assess assay conditions (buffers, cofactors, temperature, pH)
Examine detection method sensitivity and specificity
Consider protein modifications:
Design definitive experiments:
Use complementary approaches (biochemical, cellular, genetic)
Include appropriate positive and negative controls
Employ both in vitro and cellular systems
Consider structural biology approaches
Apply the principles of experimental design for art conservation research:
To elucidate the interactome of ART4, researchers can employ several cutting-edge methodologies:
Affinity-based approaches:
Proximity-based labeling:
BioID or TurboID fusion proteins to identify proximal proteins
APEX2-based approaches for temporal resolution
Controls should include catalytically inactive biotin ligase fusions
Structural and biophysical methods:
Surface plasmon resonance (SPR) for direct binding studies
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) for conformational changes
Validation strategies:
Confirm key interactions using orthogonal methods
Perform domain mapping to identify interaction interfaces
Employ functional assays to assess biological relevance
ART4 exhibits significant polymorphism, particularly in regions encoding Dombrock blood group antigens. These variations affect experimental approaches:
Sample selection and characterization:
Genotype samples for known ART4 polymorphisms
Include diverse genotypes to represent population variation
Document ethnic/ancestry information due to population differences in allele frequencies
Antibody selection considerations:
Verify antibody recognition across different ART4 variants
Use antibodies targeting conserved regions for universal detection
Employ variant-specific antibodies for distinguishing polymorphisms
Functional studies:
Compare wild-type and variant proteins in parallel
Assess whether functional differences correlate with specific polymorphisms
Consider the evolutionary conservation of polymorphic sites
Technical adjustments:
Design primers that account for known variations
Use sequencing to confirm genotypes
Consider allele-specific expression analyses
Researching rare Dombrock blood group phenotypes presents unique challenges:
Sample acquisition strategies:
Collaborate with blood banks and transfusion centers
Develop screening protocols for rare phenotypes
Consider biobanking of rare samples for sustained research
Low-input methodologies:
Optimize protocols for limited sample amounts
Employ single-cell approaches when possible
Develop targeted sequencing approaches for ART4 variants
Validation approaches:
Use multiple methodologies to confirm rare variants
Combine serological and molecular typing methods
Generate recombinant proteins expressing rare variants for functional studies
Alternative approaches when samples are unavailable:
Use CRISPR/Cas9 to introduce rare variants into cell lines
Develop computational models based on protein structure prediction
Create synthetic biology systems to mimic rare phenotypes
Advanced understanding of ART4 has implications for improving blood typing approaches:
Molecular vs. serological typing:
DNA-based Dombrock typing offers advantages in specificity
Molecular methods can detect silent alleles missed by serology
Integration into comprehensive blood group genotyping panels increases efficiency
Novel methodological approaches:
Mass spectrometry-based blood group protein profiling
Next-generation sequencing for comprehensive variant detection
Recombinant protein-based assays for antibody identification
Validation and standardization:
Reference materials for rare phenotypes
Proficiency testing across methodologies
Correlation studies between genotype and phenotype
Implementation considerations:
Cost-effectiveness analyses for new methodologies
Adaptation for resource-limited settings
Training requirements for specialized techniques
By focusing on these methodological approaches, researchers can advance our understanding of ART4 biology while contributing to improvements in transfusion medicine and hematological research.
The ART4 gene encodes a protein that contains a mono-ADP-ribosylation (ART) motif. It is a single-copy gene in humans and has homologs in other primates and mice . The protein is glycosylphosphatidylinositol (GPI)-anchored to the erythrocyte membrane, which means it is attached to the cell membrane via a GPI anchor .
The Dombrock blood group system antigens are located on the ART4 gene product. Allelic variants of ART4 can lead to adverse transfusion reactions, making it clinically significant in blood transfusion medicine . Additionally, ART4 has been implicated in various cellular processes, including the regulation of cellular metabolism and the immune response .